Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH
(NASDAQ: AKRO) Delayed: 54.74 --0 (-0%)
Previous Close $54.74    52 Week High $ 
Open $54.74    52 Week Low $ 
Day High $54.74    P/E N/A 
Day Low $54.74    EPS $ 
Volume 3,685,186